Camp Lejeune Case – Lead lawyers appointed in Camp Lejeune litigation – The judges in charge of the case about the water contamination on Marine Corps Base Camp Lejeune have appointed attorneys from Lieff Cabraser Postman, the Keller Postman, Bell Legal Group and four other law firms to form a seven-member leadership group on behalf of the plaintiffs.
Johnson & Johnson’s must pay $18.8 million to California cancer patient in baby powder lawsuit – A jury found on Tuesday that Johnson & Johnson must pay $18.8 million to a California man who claimed he contracted cancer after using the firm’s baby powder. This is a blow for the corporation as it works to resolve thousands of other cases involving its talc-based products in the U.S. bankruptcy court.
US FDA classifies recall of Johnson & Johnson’s electrosurgical tools as most serious – The U.S. Food and Drug Administration (FDA) on Tuesday categorized a recall for specific electrosurgery instruments produced by the Johnson & Johnson unit (JNJ.N) as “most serious” and warned that the use of these tools could result in deaths or injuries.
Jurors urged to impose heavy punitive damages in Johnson & Johnson talc trial – Lawyers representing the California man who claims to have suffered rare cancer as a result of exposure to asbestos contained in Johnson and Johnson’s (JNJ.N) baby powder made of talc on Monday urged a juror to make the company pay hefty punitive damages the company’s conduct as reckless as well as “despicable.”
L’Oreal says ‘vague’ hair-relaxer product claims should be thrown out – Affiliates from a French company that makes cosmetics L’Oreal (OREP.PA), as well as other companies in the beauty industry, have requested a U.S. judge to dismiss claims that they produced and sold harmful hair-relaxing chemicals that can cause cancer and other health issues.
First trial over Zantac cancer claims set for November – First U.S. trial over claims that the heartburn medication Zantac causes cancer is set to be held within California the state court of November. 13th A lawyer representing plaintiffs in the lawsuit told reporters on Friday.
Where Will Johnson & Johnson Be in 5 Years?
– The returns on the stock over the last decade haven’t been very good. Should investors be expecting this to change?
J&J’s $8.9 billion talc settlement faces US bankruptcy test – Johnson and Johnson’s (JNJ.N) proposed $8.9 billion settlement of lawsuits that claim the talc product causes cancer is facing a major obstacle this week when a U.S. bankruptcy judge in New Jersey considers whether or whether a J&J subsidiary could resolve the matter with bankruptcy again.
The Impact Of The Tylenol Autism Lawsuit On The Pharmaceutical Industry: A Critical Evaluation – The Tylenol autism lawsuit had a profound impact on the industry of pharmaceuticals, since it questioned the security of Tylenol products that contain acetaminophen. They claimed that they cause an increase in autism symptoms among kids.
3M Reaches Tentative $10.3 Billion Deal Over US ‘Forever Chemicals’ Claims – 3M Co has reached a $10.3 billion settlement with several U.S. public water systems to settle water pollution claims resulting from “forever chemical products,” The chemical firm announced its announcement on Thursday.
